Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors

被引：30

作者：

Gou, Hongna ^{[1
,2
]}

Pan, Yang ^{[3
]}

Ge, Hongwei ^{[4
]}

Zheng, Yourong ^{[5
]}

Wu, Yaling ^{[6
]}

Zeng, Jinfeng ^{[7
]}

Yang, Zhongsi ^{[8
]}

Pan, Tong ^{[9
]}

Cun, Wei ^{[10
]}

Zhou, Guoping ^{[11
]}

Fang, Gen ^{[12
]}

Zhang, Jiahong ^{[13
]}

Zhang, Kuo ^{[1
]}

Zhang, Rui ^{[1
]}

Sun, Yu ^{[1
]}

Xie, Jiehong ^{[1
]}

Li, Jinming ^{[1
]}

Wang, Lunan ^{[1
]}

机构：

[1] Chinese Acad Med Sci, Natl Ctr Clin Labs, Beijing Hosp, Beijing 100730, Peoples R China

[2] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing 100730, Peoples R China

[3] Beijing Ctr Dis Prevent & Control CDC, Inst Infect Dis & Endem Dis Control, Beijing, Peoples R China

[4] Beijing Blood Ctr, Beijing, Peoples R China

[5] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China

[6] Zhejiang Blood Ctr, Hangzhou, Zhejiang, Peoples R China

[7] Shenzhen Blood Ctr, Shenzhen, Peoples R China

[8] Qingdao Blood Ctr, Qingdao, Peoples R China

[9] Tianjin Blood Ctr, Tianjin, Peoples R China

[10] Kunming Blood Ctr, Kunming, Peoples R China

[11] Shanghai Blood Ctr, Shanghai, Peoples R China

[12] Neimenggu Blood Ctr, Neimenggu, Peoples R China

[13] Tongzhou Blood Ctr, Beijing, Peoples R China

来源：

TRANSFUSION | 2015年 / 55卷 / 09期

关键词：

OCCULT HBV INFECTION; TRANSMISSION RISK; WINDOW PERIOD; TEST OPTIONS; EPIDEMIOLOGY; SENSITIVITY; COMPONENTS; ASSAYS;

D O I：

10.1111/trf.13135

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BACKGROUND: This multicenter study was performed to evaluate the efficiency of a multiplex individual-donation nucleic acid amplification technology (ID-NAT) and discriminatory testing algorithm for detecting hepatitis B virus (HBV) infection in Chinese blood donors. STUDY DESIGN AND METHODS: A total of 1,205,796 hepatitis B surface antigen (HBsAg)nonreactive donations from 10 blood centers were tested by ID-NATusing the Ultrio assay. Multiplex Ultrio-reactive donations were tested in the discriminatory tests as well as in quantitative polymerase chain reaction (qPCR) and in supplemental electrochemiluminescence immunoassays for HBsAg, hepatitis B surface antibody (anti-HBs), hepatitis B e antigen, and antibody to hepatitis B core antigen (anti-HBc). Meanwhile, a control group of 4317 Ultrio-nonreactive donations was tested for anti-HBc and anti-HBs. RESULTS: Of all donations, 2033 (0.17%) were reactive in the multiplex Ultrio assay. Among 1776 further tested samples, 548 (30.9%) were HBV discriminatory assay (dHBV)-reactive, while 1214 (68.4%) were nonreactive. Of 472 Ultrio+ and dHBV+ samples 86.2% were qPCR positive compared to 15.0% in 1046 Ultrio+ and dHBVsamples. The proportion of anti-HBc+ and anti-HBs( potentially infectious) donations was higher in 409 Ultrio+ and dHBV+ than in 1028 Ultrio+ and dHBVsamples (51.3% vs. 31.1%, p < 0.001). The yield rate of Ultrio+, dHBV+, and qPCR+ donations was estimated at 1 in 2500, but at 1 in 1100 when all supplemental tests were taken into account assuming that 44% of detected donations by Ultrio were false reactive. CONCLUSIONS: A quarter of HBsAg-negative Ultrio+ and dHBV-donations in China are likely given by potentially infectious low-viral-load occult carriers. Although this has no implication for blood safety, the testing algorithm needs to be redesigned to more efficiently discriminate between true and false NATreactivity.

引用

页码：2272 / 2281

页数：10

共 50 条

[41] Cost-benefit analysis of serological and nucleic acid testing for hepatitis B virus in blood donors in southern China
Ye, Xianlin
Xiong, Wen
Xu, Xiaoxuan
Zeng, Jinfeng
Xie, He
Li, Bin
He, Baoren
Chen, Limin
Mo, Qiuhong
BMC INFECTIOUS DISEASES, 2024, 24 (01)
[42] Nucleic acid testing for virus screening in Polish blood donors
Brojer, E
Lètowska, M
Gronowska, A
TRANSFUSION MEDICINE, 2004, 14 (01) : 79 - 80
[43] Tissue donation and virus safety: more nucleic acid amplification testing is needed
Pruss, A.
Caspari, G.
Kruger, D. H.
Blumel, J.
Nubling, C. M.
Gurtler, L.
Gerlich, W. H.
TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (05) : 375 - 386
[44] Nucleic acid testing of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus 1, 2 in blood donors in the General University Hospital, Prague
Duskova, D.
Darebnicek, L.
ACTA VIROLOGICA, 2014, 58 (02) : 146 - 151
[45] Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
Stramer, Susan L.
Notari, Edward P.
Krysztof, David E.
Dodd, Roger Y.
TRANSFUSION, 2013, 53 (10) : 2449 - 2458
[46] Prolonged incubation period of hepatitis B in a recipient of a nucleic acid amplification test-negative hepatitis B virus window donation
Matsuno, Takahiro
Matsuura, Hideaki
Fujii, Sumie
Tanaka, Ami
Satake, Masahiro
Kinoshita, Tomohiro
Tomita, Akihiro
Matsui, Yusuke
Sugiura, Yukari
Miura, Yasuo
TRANSFUSION, 2021, 61 (09) : 2782 - 2787
[47] Blood donor screening with nucleic acid amplification tests for human immunodeficiency virus, hepatitis C virus and hepatitis B virus
Kleinman, S.
ISBT SCIENCE SERIES, VOL 3, NO 1, 2008, 3 (01): : 191 - 195
[48] Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region
Stolz, Martin
Tinguely, Caroline
Graziani, Mauro
Fontana, Stefano
Gowland, Peter
Buser, Andreas
Michel, Martine
Canellini, Giorgia
Zueger, Max
Schumacher, Philippe
Lelie, Nico
Niederhauser, Christoph
TRANSFUSION, 2010, 50 (12) : 2695 - 2706
[49] Individual hepatitis B virus nucleic acid testing (HBV-NAT) on 61.825 blood donations in Madrid, Spain
Gonzalez, R.
Echevarría, J. M.
Avellon, A.
Barea, L.
Bueno, J. L.
Castro, E.
VOX SANGUINIS, 2006, 91 : 80 - 80
[50] Hepatitis G virus infection in screened Chinese blood donors
Ren, FR
Wang, Y
Li, H
Chen, HS
Zhao, HY
VOX SANGUINIS, 1998, 74 (01) : 51 - 52

← 1 2 3 4 5 →